AstraZeneca PLC (AZN) Puts 'For Sale' Sign on U.S. HQ
Biotechs are Expanding in the Bay Area Again: Bristol-Myers Squibb (BMY), Genentech (RHHBY), Gilead (GILD), Illumina (ILMN) and Verily and More
Amidst Dramatic Reorganization, Takeda (TKPYY) May (Or May Not) Shutter Cambridge, UK Site
Embattled Theranos Plans to Appeal to Re-Open Its Lab in Newark, California
Mylan (MYL) Isn't Alone: 11 Drug Companies With Muscular Pricing Power and Staggering Profit Margins
What You Don't Know: Pfizer (PFE)’s Connection to Mylan (MYL) and EpiPen
Bay Area Life Sciences VC Firm Sofinnova Scores $595.5 Million
Alere (ALR) Drags Abbott (ABT) to Court to Force Completion of $5.8 Billion Deal
Merck & Co. (MRK)'s Keytruda May Have an Edge Over Bristol-Myers Squibb (BMY)'s Opdivo for Cancer Doctors
Adocia's Foot Ulcer Med Flunks Phase III Test
Novan Files Paperwork for $60 Million IPO to Develop Skin Drugs
Vanda (VNDA) Investors Elated Over Drug Patent Ruling
FDA Slaps Warning on Sun Pharma (SUNPHARMA.NS)'s Former U.S. Facility for Releasing Drug Despite Contamination Issues
Job Cuts Loom as Takeda (TKPYY) to Shutter Cambridge Office and Quits the UK
These Biotech Employers Hired the Most New Grads In Life Sciences
How Pfizer (PFE)’s Antibiotics Buy from AstraZeneca PLC (AZN) Will Affect Jobs in the U.S.
Led by Former Genentech (RHHBY) Execs, Denali Banks $130 Million, Initiates Trial and Announces a Handful of Partnerships
Medivation (MDVN) Exec Jumps Ship to Become CMO at BeiGene (BGNE)
See All News >
//-->